ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,571Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 625

$676K Total Retail Price of All Prescriptions

Rank: 18 out of 625

201 Patients Receiving at Least One Drug in Part D
44%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 1,352 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$121 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 7.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
RISPERIDONE 365 45 1 41
TRAZODONE HCL 329 65 2 31
LOVAZA 320 35 3 86
CITALOPRAM HBR 310 40 4 30
QUETIAPINE FUMARATE 300 77 5 64
DIVALPROEX SODIUM ER 263 22 6 134
ABILIFY 223 19 7 59
NAMENDA 213 187 8 63
BUSPIRONE HCL 212 92 9 152
DIVALPROEX SODIUM 206 33 10 76
ESCITALOPRAM OXALATE 181 36 11 122
TOPIRAMATE 169 12 12 102
SEROQUEL 161 36 13 181
GUANFACINE HCL 152 0 R 14 203
LITHIUM CARBONATE 147 0 15 200
GABAPENTIN 128 19 16 12
EXELON 128 116 16 185
PINDOLOL 125 0 18 247
SEROQUEL XR 112 0 19 124
SERTRALINE HCL 101 65 20 35
PROPRANOLOL HCL 101 0 20 149
CYMBALTA 82 67 22 82
DONEPEZIL HCL 69 48 23 49
ZIPRASIDONE HCL 66 0 24 203
BENZTROPINE MESYLATE 58 0 R 25 148
NALTREXONE HCL 53 0 26 322
MIRTAZAPINE 52 25 27 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 5, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.